Distribution — Strategy

🟣 Distribution

Mandate: generate qualified demand and convert it into paid orders — profitably and on-brand. Distribution feeds Operation (orders to fulfil) and Capital (revenue to bank).

Objective & guardrail

Grow revenue per month while holding blended ROAS ≥ 2.0 and keeping every message in research-use framing (no dosing/medical claims — this is non-negotiable and is what keeps the brand alive).

Funnel

Awareness  → Interest → Consideration → Purchase → Retention
(content)    (lead)      (nurture)       (order)    (membership/repeat)

Stage	What we do	Logged as
Awareness	TikTok/IG/Threads/X content, SEO blog, COA transparency	#content-post
Interest	DM/WhatsApp enquiry, profile/link click	#lead
Consideration	Answer questions, send guides, offer bundle fit	#lead (status nurturing)
Purchase	Website checkout or WhatsApp-assisted order	#sales-order
Retention	Membership, reorder nudges, newsletter	#campaign (retention)

Channels (current)

Instagram · Threads · X · Telegram (@indexalabs) · TikTok · WhatsApp enquiry · Email (newsletter). TikTok is the top-of-funnel engine; WhatsApp is the close. Website is the system of record for orders.

Offer architecture

• On-demand singles — ~30 peptides (BPC-157, Retatrutide, MOTS-C, GHK-Cu, PT-141, Epithalon …).
• Curated bundles — the conversion drivers, grouped by goal: To Feel Good, Shred, Lean & Mean, Glow Up, Deep Sleep, Longevity Stack, Wolverine Protocol and more.
• Promotions: Free shipping > RM200 · Free shipping + 10% > RM500.
• Trust assets: third-party COA / test reports, product Verify, order tracking. These are the marketing — research buyers convert on proof.

Content pillars

1. Education — what a peptide is, reconstitution, storage, reading a COA.
2. Product — bundle spotlights, goal-based stacks, new arrivals.
3. Social proof — COA results, verification, reviews, transparency.
4. Promo — offers, bundles, free-shipping thresholds.
5. Research / Literature — cite PubMed/PMC papers, white papers, tier lists; authority via real science. See Content — Playbook.

Full content strategy, the Threads alias-brand rule, accounts to study, and brand benchmarks live in Content — Playbook.

Weekly operating rhythm

Plan content 7 days ahead (all scheduled) · keep one promo live · update every live campaign’s spend/revenue · reply to and qualify every inbound lead within 24h · review ROAS and kill anything under 1.5 after a fair test.

Bases

• Sales Orders — every order, status, value.
• Leads — pipeline from new → won/lost.
• Campaigns — spend, revenue, live ROAS.
• Content Calendar — what’s shipping, by channel & date.

SOPs

• SOP — Content Publishing
• SOP — Campaign Launch
• SOP — Lead to Sale

Competitive landscape

Track rivals’ pricing and positioning to inform our own. Key finding: we sit well below premium branded sellers — room to raise prices behind our COA/Verify trust edge.

• Olymp Peptides — premium-priced, branded. Reta 60mg RM1,300 (vs our RM400); GHK-Cu 100mg RM450 (vs RM100).
• All competitors: Competitors

Brand benchmarks

These are not competitors — they’re the brands whose look, voice, and distribution machinery we want to grow into. Most are licensed-clinician telehealth (a different regulatory model from ours), so we copy their brand and distribution mechanics, never their medical/dosing claims. Our guardrail is unchanged: research-use framing, COA/Verify as the proof engine. AgelessRx and Voy are the north stars; the rest are the supporting roster, each picked for one transferable move.

How to read this: ignore their drug claims, study how they earn trust, package an offer, and move a stranger to a paying, repeating customer.

North stars

AgelessRx — US longevity telehealth. Positioning: not general telehealth — specifically “slow/reverse aging,” healthspan-led, every protocol reviewed by a provider. Why strong: authority is the product. A Stanford-PhD research team runs its own trials; “monitoring + bloodwork included” reframes price as safety, not cost. 30+ protocols sold as goal-based stacks. Distribution: subscription + automatic refills = built-in retention; protocol catalog + “longevity journey” framing drives reorders. Steal for Indexa: lean into our Research / Literature pillar as the brand’s spine — cite the science, show the COA, let proof do the selling. Package singles into goal-based stacks (we already do: Longevity Stack, Wolverine) and frame every label as “verified / third-party tested,” our version of “monitoring included.”

Voy — UK GLP-1 / metabolic telehealth (Manual’s weight-loss sub-brand; 100k+ members in 18 months). Positioning: calm, anti-hype “proactive companion,” explicitly not a “pill-mill.” Clinical but warm. Why strong: a companion app + human coach + AI assistant (Joy) turns a transactional refill into an ongoing relationship; a results guarantee (“10% in 6 months or money back”) sells confidence. Distribution: subscription with coaching baked in; consult → clinician review → ship → ongoing app engagement = high retention. Steal for Indexa: the muted, clinical-but-human visual language is exactly our packaging/labelling upgrade target. Our “companion” is cheaper to build: a WhatsApp/Telegram close + reorder nudges + reconstitution/storage guides that make a buyer feel supported, not just sold to.

Supporting roster

Function Health — membership lab testing (~$365/yr, 160+ biomarkers). Steal: data/proof is the product. Mirrors our COA/Verify edge — position transparency as a paid, recurring value, not a giveaway. Membership = predictable revenue.

Superpower — viral biomarker testing; grew via organic content, not ads. Steal: the most relevant to our TikTok + Threads paths. Shareable proof artifacts (their “Bio Age cards,” a hoodie drop) = build our shareable COA-reveal / “verify your vial” content and let users spread it. Growth without ad spend protects ROAS.

Eden — GLP-1 DTC with flat, transparent pricing (no price hikes as dose climbs). Steal: radical pricing transparency as a trust weapon — the pricing analogue of our COA transparency. Publish clear prices and free-shipping thresholds; never make the buyer feel a hidden markup.

Novos — longevity supplements “designed by aging researchers,” accessible price, explicitly counter-positioned against Bryan Johnson’s $2M Blueprint. Steal: the “serious science, accessible price” lane — exactly where we sit vs premium sellers like Olymp. Authority without elitism; we undercut on price while out-proving on COA.

Maximus Tribe — performance/men’s telehealth; tiered protocol packs (microdose → starter → custom). Steal: tiered protocol packaging validates our bundle architecture. Offer clear entry → standard → advanced tiers so an agent can upsell along a ladder instead of selling one SKU.

Numan — UK men’s health; building “a consumer brand around healthcare,” destigmatising, expanding into a “complete health partner.” Steal: brand-first, category-expansion thinking — one consistent identity across every channel and agent (our Brand-improvement pipeline), then widen from peptides into adjacent goals once trust is banked.

Regional / closest-analogue watchlist

• And Sons — closest Malaysian DTC men’s-health analogue; study local tone, payment, and trust cues for the MY market.
• Medvi — US GLP-1 telehealth; clean conversion-focused funnel worth modelling.

Voice & personality accounts to study live in the content memory: brand voice → @my.officialpeptide, @peptides.my, @nexapeps, @kolektifgreymatter; long-form personality → @abambotax, @poly.peppers.